Compare MYGN & THRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MYGN | THRM |
|---|---|---|
| Founded | 1991 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 444.2M | 844.7M |
| IPO Year | 1996 | 1996 |
| Metric | MYGN | THRM |
|---|---|---|
| Price | $5.00 | $28.43 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 5 |
| Target Price | $7.64 | ★ $38.60 |
| AVG Volume (30 Days) | ★ 1.3M | 190.3K |
| Earning Date | 05-05-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.59 |
| Revenue | ★ $771,400,000.00 | $554,979,000.00 |
| Revenue This Year | $6.89 | $4.90 |
| Revenue Next Year | $5.35 | $7.19 |
| P/E Ratio | ★ N/A | $48.43 |
| Revenue Growth | 2.33 | ★ 50.16 |
| 52 Week Low | $3.76 | $23.67 |
| 52 Week High | $8.59 | $39.48 |
| Indicator | MYGN | THRM |
|---|---|---|
| Relative Strength Index (RSI) | 56.21 | 44.32 |
| Support Level | $4.23 | $27.02 |
| Resistance Level | $5.67 | $29.37 |
| Average True Range (ATR) | 0.29 | 0.79 |
| MACD | 0.07 | 0.22 |
| Stochastic Oscillator | 70.69 | 50.56 |
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.
Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the USA, China, South Korea, Germany, Japan, the Czech Republic, and other countries.